Infectious Diseases of the 21st Century: A New World Order

Inaugural address of the Norman L. Ford Science Literacy Lecture Series by Dr. Michael Osterholm : Infectious Diseases of the 21st Century: A New World Order 7:30 p.m., Sept. 29, 2015Pellegrene Auditorium, Saint John\u27s University Dr. Michael Osterholm is the McKnight Presidential Endowed Chair in Public Health, director of the Center for Infectious Disease Research and Policy, and Regents Professor at the University of Minnesota. He is a member of the National Academy of Medicine, the Council of Foreign Relations and the National Science Advisory Board on Biosecurity. He is an international leader on public health preparedness for infectious diseases and the use of biological agents as weapons targeting civilian populations, and he is the author of more than 325 papers and abstracts, including 21 book chapters. Dr. Osterholm is widely recognized as a dynamic public speaker with a gift for making science accessible to all. Read more about Dr. Osterholm

Public Health in the Age of Ebola in West Africa

The Ebola epidemic, with its fast-growing toll and real potential for spreading into much of Africa, including major cities, has the makings of a “Black Swan” event. Such events, using the term coined by Nassim Nicholas Taleb, are: 1) unpredictable, outside the realm of regular expectations; 2) have a major impact, and; 3) are rationalized after the fact as being explainable and predictable. We have learned from this outbreak the potential for an infectious disease to be politically, economically, and socially destabilizing, and that what kills us may be very different from what frightens us or substantially affects our social systems. This has important implications for resource allocation. Health threats like Ebola may not have historically have not killed large numbers of people, but because of possible scenarios under which they can have a devastating impact, require a greater share of limited resources, such as for developing a vaccine. More creative imagination is needed in considering future infectious disease scenarios and in planning accordingly. Further, this Ebola epidemic could transform global governance for health. It demonstrates the need for fundamental reform at the WHO, including for greater funding, as WHO\u27s response–unable to mobilize sufficient funding, too slow to declare this a Public Health Emergency of International Concern–indicates that the Organization is presently poorly positioned to fulfill its constitutional role as the global health authority. Meanwhile, the leadership role that the United Nations is assuming suggests the emergence of an era of direct United Nations engagement in health threats that could destabilize nations and regions

Redaction of sensitive data in the publication of dual use research of concern

Editorial. The publication of scientific information that derives from dual use research of concern (DURC) poses major problems for journals because it brings into conflict the benefits of free access to data and the need to prevent misuse of that information by others. Recently, a group of authors and a major scientific journal addressed the issue of publishing information on a newly discovered, highly lethal toxin that can be delivered to large populations and for which there are no available countermeasures. The journal addressed this conflict by permitting the redaction of information that is normally considered essential for publication. This action establishes a precedent for redaction of sensitive data that also provides an example of responsible scientific publishing. However, this precedent leaves many questions unanswered and suggests a need for a discussion by all stakeholders of scientific information so as to derive normative standards for the publication of DURC

Social, cultural and economic aspects of antimicrobial resistance.

Although often considered only a medical problem, antimicrobial resistance is an evolutionary challenge accelerated by social, cultural and economic factors that lead to the misuse, overuse and abuse of life-saving antimicrobial medicines. The antimicrobial resistance challenge is compounded by inadequate attention to disease prevention and response, global circulation of people and products, differences in industry and market regulations across countries, and a fragile pipeline of new antibiotics and their alternatives. While the discovery of new antimicrobials will provide temporary solutions, sustainable success requires rigorous social science research that explores the drivers of antimicrobial resistance. These solutions should promote balance between equitable access to, conservation of, and innovation for antimicrobials, adapted to local conditions across the globe

Global leadership at the crossroads: Are we prepared for the next pandemic?

"In this report, the Scowcroft Institute of International Affairs at The Bush School of Government & Public Service at Texas A&M University outlines eight priority areas and their accompanying recommended action items to address vulnerabilities in the current pandemic preparedness and response system. Collectively, they represent issues the international community should address in order to establish pandemic preparedness and response capabilities." -- p. 5

Pandemic Influenza Planning in Nursing Homes: Are We Prepared?

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/66316/1/j.1532-5415.2007.01299.x.pd

Adaptations of Avian Flu Virus Are a Cause for Concern

We are in the midst of a revolutionary period in the life sciences. Technological capabilities have dramatically expanded, we have a much improved understanding of the complex biology of selected microorganisms, and we have a much improved ability to manipulate microbial genomes. With this has come unprecedented potential for better control of infectious diseases and significant societal benefit. However, there is also a growing risk that the same science will be deliberately misused and that the consequences could be catastrophic. Efforts to describe or define life-sciences research of particular concern have focused on the possibility that knowledge or products derived from such research, or new technologies, could be directly misapplied with a sufficiently broad scope to affect national or global security. Research that might greatly enhance the harm caused by microbial pathogens has been of special concern (1–3). Until now, these efforts have suffered from a lack of specificity and a paucity of concrete examples of “dual use research of concern” (3). Dual use is defined as research that could be used for good or bad purposes. We are now confronted by a potent, real-world example

A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future

Improved influenza vaccines are urgently needed to reduce the burden of seasonal influenza and to ensure a rapid and effective public-health response to future influenza pandemics. The Influenza Vaccines Research and Development (R&D) Roadmap (IVR) was created, through an extensive international stakeholder engagement process, to promote influenza vaccine R&D. The roadmap covers a 10-year timeframe and is organized into six sections: virology; immunology; vaccinology for seasonal influenza vaccines; vaccinology for universal influenza vaccines; animal and human influenza virus infection models; and policy, finance, and regulation. Each section identifies barriers, gaps, strategic goals, milestones, and additional R&D priorities germane to that area. The roadmap includes 113 specific R&D milestones, 37 of which have been designated high priority by the IVR expert taskforce. This report summarizes the major issues and priority areas of research outlined in the IVR. By identifying the key issues and steps to address them, the roadmap not only encourages research aimed at new solutions, but also provides guidance on the use of innovative tools to drive breakthroughs in influenza vaccine R&D.publishedVersio

Endogenous antigen processing drives the primary CD4+ T cell response to influenza.

By convention, CD4+ T lymphocytes recognize foreign and self peptides derived from internalized antigens in combination with major histocompatibility complex class II molecules. Alternative pathways of epitope production have been identified, but their contributions to host defense have not been established. We show here in a mouse infection model that the CD4+ T cell response to influenza, critical for durable protection from the virus, is driven principally by unconventional processing of antigen synthesized within the infected antigen-presenting cell, not by classical processing of endocytosed virions or material from infected cells. Investigation of the cellular components involved, including the H2-M molecular chaperone, the proteasome and γ-interferon-inducible lysosomal thiol reductase revealed considerable heterogeneity in the generation of individual epitopes, an arrangement that ensures peptide diversity and broad CD4+ T cell engagement. These results could fundamentally revise strategies for rational vaccine design and may lead to key insights into the induction of autoimmune and anti-tumor responses